Pharma Marketing Network

MARCH 23, 2023

Pharmaceutical companies have made major strides in developing new treatments for Alzheimer’s disease, offering hope for the millions of people affected by this debilitating condition. However, recent advancements in research have resulted in new drugs that show promising results in slowing the progression of the disease.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Vaccines Drug Development 52

pharmaphorum

JANUARY 31, 2022

The digital transformation is allowing pharmaceutical companies to expand their drug discovery capabilities and accelerate drug development. The result was four innovative solutions for generating awareness about the importance of vaccines and improving vaccine access and administration.

Vaccines 97

Vaccines Pharmaceutical Companies Pharmaceutical Companies Drug Development 97

pharmaphorum

JANUARY 27, 2023

Late last year, pharmaphorum caught up with Dr Karen Mullen, chief medical officer and VP of clinical & medical affairs at global drug development consultancy Boyds. We talk a lot in clinical trials and drug development about benefit,” Dr Mullen said. But who is benefitting?

Vaccines 111

Vaccines Pharmaceutical Companies Pharmaceutical Companies Documentation 111

pharmaphorum

AUGUST 31, 2021

However, like many other emerging healthcare technologies, they have been slow to gain traction and there is still confusion and scepticism around ECAs, stemming from a lack of precedence, step-by-step guidance and data to quantify their impact on drug development costs and clinical outcomes.

Insurance Coverage and Processing 89

Insurance Coverage and Processing Drug Development Documentation Labelling 89

Pharmaceutical Technology

NOVEMBER 4, 2022

Goods were largely delivered on time, and at a low cost, benefitting both companies and consumers. By 2021, social media mentions of supply chains reached 25,636. For the pharmaceutical industry, disorder in the supply chain can be catastrophic especially when it comes to life saving and sustaining drugs. Time to evolve.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Vaccines Drug Development 52

European Pharmaceutical Review

OCTOBER 19, 2022

Patents are often described as the ‘lifeblood’ of pharmaceutical companies. 1 However, patent protection for pharmaceutical products is an economic trade-off between providing monopoly rights that incentivise development of future products and permitting higher drug prices to recoup the investment. 2020-02-24.

Biosimilars 96

Biosimilars Dosage Drug Pricing Pharmaceutical Companies 96

Viseven

JANUARY 4, 2023

This article will cover the most important areas of AI influence on the pharma industry and new drugs development. What is Artificial Intelligence in Pharmaceutical Industry? Drug Development and Discovery. We analyzed the recent market research and are ready to share it with you. Manufacturing process.

Drug Development 52

Drug Development Medical Records Communication Pharmaceutical Companies 52

pharmaphorum

APRIL 19, 2022

The difficulty in gaining approval turned out to be an unexpected blessing, as one of those experts would connect the company to Hanlim, its first pharma partner. “In In early 2021, a scientific advisor who was impressed with RCI001, introduced us to several people from Hanlim,” Kim said. Moving to the global stage. Conclusion.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication Drug Development 52

pharmaphorum

JUNE 2, 2022

In 1983, the US Congress passed the Orphan Drug Act to encourage more pharmaceutical companies to engage in R&D to develop treatments for rare diseases through the offering of financial incentives. By 2026, the report predicts that each of the top 10 selling orphan drugs will earn between $3 billion and $13 billion.

Compounding 52

Compounding Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 52

European Pharmaceutical Review

SEPTEMBER 2, 2022

She has worked with regulatory agencies and pharmaceutical companies for over 10 years. US Food and Drug Administration. Patient-Focused Drug Development: Collecting Comprehensive and Representative Input Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholders; June 2020.

Adverse Reactions 96

Adverse Reactions Documentation Medical Schools Packaging 96

pharmaphorum

FEBRUARY 9, 2021

Alongside its support for research carried out by patients, advocacy groups, pharmaceutical companies, and academic medical centers, Rare Central also enables scientists and researchers to study deidentified data across a family of diseases with the appropriate governance structure and data sharing in place. A Decade of Experience.

Compounding 98

Compounding Pharmaceutical Companies Pharmaceutical Companies Drug Development 98

PharmaShots

FEBRUARY 21, 2023

Market Cap: $21.06M Founded Year: 2021 Total Employees: ~10 Headquarters: Victoria, Australia Stock Exchange: ASX Radiopharm Theranostics is a biotech company focused on developing radiopharmaceuticals for diagnosing and treating diseases with high unmet medical needs. In 2021, Xofigo generated a sale of $75.08M.

Dosage 56

Dosage Labelling Immunity Immunization 56

Pharmaceutical Technology

DECEMBER 9, 2022

M&A – Commended PRODUCT LAUNCHES – Commended RESEARCH AND DEVELOPMENT – Commende d. Pharmaceutical Technology Excellence Rankings – The Verdict. Solvias is a Swiss-based pharmaceutical company focused on contract research, development and manufacturing.

Vaccines 52

Vaccines Biosimilars Compounding Packaging 52

Express Pharma

JULY 10, 2024

She also suggests, “India can foster collaboration between the IT and the biopharma companies through government or private initiated collaborative channels – these can help facilitate discussions around latest technological advancements available that could help in overcoming challenges in biopharma drug development and advancement.”

Vaccines 96

Vaccines Drug Development Process Improvement Biosimilars 96

PharmaShots

MARCH 6, 2023

Traditionally patients were viewed by pharmaceutical companies as simply users of our products, nowadays they are considered partners working towards a collective goal. As a result of this progression, our industry developed the notion of patient-centricity. AI can play an important role in diagnosis, too.

Drug Development 40

Drug Development Immunity Immunization Pharmaceutical Companies 40

pharmaphorum

SEPTEMBER 9, 2021

million cancelled operations by the end of 2021. Janssen currently has more than 150 partnerships in play , with a view to developing and delivering new products that can advance scientific research and provide value to patients, physicians, and healthcare systems around the world. This will, inevitably, take longer in some areas.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies Hospitals 52

Pharmaceutical Technology

DECEMBER 22, 2022

In 2021 the company announced that 97% of its electricity usage had been obtained from renewable sources such as wind, solar, hydroelectric, and biomass, with this increasing further in 2022. The category also includes projects that contribute to the environment such as tree planting schemes and river cleaning.

Diabetes 52

Diabetes Biosimilars Pharmaceutical Companies Pharmaceutical Companies 52

PharmaShots

APRIL 10, 2023

The 2021 data reflects 537M affected people, with the predominant population living in low- and middle-income countries Type 2 diabetes mellitus (T2DM), unlike Type 1 diabetes mellitus (T1DM) is a lifestyle-affected disease mostly seen due to a sedentary lifestyle, lack of exercise, and improperly planned diet.

Diabetes 40

Diabetes Biosimilars Pharmaceutical Companies Pharmaceutical Companies 40

Pharmaceutical Technology

FEBRUARY 1, 2023

RSV researchers at major pharmaceutical companies are currently working to develop new RSV drugs to beat future waves of RSV infection and gain the first RSV vaccine FDA approval. This is a significant increase compared to the 2021–20 season when the rate was 28.3 per 100,000.

Vaccines 64

Vaccines Drug Development Pharmaceutical Companies Pharmaceutical Companies 64

European Pharmaceutical Review

DECEMBER 21, 2022

“As the contribution of costs of organic chemicals used as feedstock to the operating expenditures is small, the pharmaceutical companies can spearhead and guide the transition.” He is currently group leader of the Technology Development and Discovery Group at the Bioprocess Laboratory of the ETH. Molnár A, Papp A.

Compounding 97

Compounding Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 97

Pharmaceutical Technology

DECEMBER 6, 2022

HPAPIs may now represent more than 30% of the drug development pipeline. Within that figure, GlobalData estimates that around 60% of pipeline HPAPIs are developed to target oncology. In the early stages of drug development, protecting operators from unknown risks is absolutely crucial.

Drug Development 52

Drug Development Dosage Pharmaceutical Manufacturing Communication 52

Pharmaceutical Technology

APRIL 12, 2023

In 2021, they accounted for 0.2% However, according to the US Food and Drug Administration (FDA), non-human primates are still the most scientifically relevant large model to test biologic drugs for safety. 2021 was a year of continued innovation and change in the Biopharmaceutical industry.

Vaccines 98

Vaccines Biosimilars Communication Pharmaceutical Companies 98

Pharmaceutical Technology

DECEMBER 9, 2022

Pharmaceutical sales in Brazil reached $17bn in 2021, according to GlobalData figures. Despite this, Brazil’s trade protectionist policies mean that there are few pharmaceutical companies of international origin within the country. by 2040 based on statistics from OECD. </p> By Tanner Pharma Group.

Drug Pricing 98

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Biosimilars 98

Pharmaceutical Technology

FEBRUARY 28, 2023

For many years, the pharmaceutical industry has been accused of overlooking this patient population by instead targeting investments toward more prevalent indications. Orphan drug development is expanding Change is happening. With similar incentives offered by EU/EEA and UK law, orphan drug development has taken off.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Drug Development Communication 52

Pharmaceutical Technology

MARCH 22, 2023

According to the GlobalData report Contract Injectable Packaging Trends in the Bio/Pharma Industry , more than half (55%) of FDA drug approvals in 2021 were accounted for by injectables. Several drug development trends are driving injectables demand. This was higher than the number of approvals in 2019 and 2020.

Packaging 52

Packaging Compounding Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

APRIL 12, 2023

Evidence suggests that API manufacturing is gaining in complexity, as well as sophistication, and therefore adding to the risk profile of drug development. PAT, used correctly, should lead to better manufacturing processes and ultimately significant business benefits for the pharmaceutical company.

Controlled Substances 52

Controlled Substances Dosage Communication Pharmaceutical Companies 52